SCHEMBL22926630

SCHEMBL22926630

CN1CCN(C(=O)c2ccc(-c3ccc4[nH]cnc4c3)cc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 4/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ HPGD P15428 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ MAP3K11 Q16584 1/20 0.50
▸ RIPK1 Q13546 1/20 0.49
▸ ALK Q9UM73 1/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ CHKA P35790 1/20 0.48
▸ MAPKAPK2 P49137 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.47
▸ PIK3CA P42336 1/20 0.47
▸ KCNH2 Q12809 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ HRH4 Q9H3N8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3153203 0.90 SMN1; SMN2 (0.57) POLBSMN1; SMN2HPGDKDM4EALDH1A1
SCHEMBL16151078 0.87 SMN1; SMN2 (0.47) POLBSMN1; SMN2HPGDKDM4EALDH1A1
SCHEMBL16156045 0.84 CRBN (0.52) POLBSMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL17389617 0.84 FASN (0.66) —
SCHEMBL17390054 0.83 FASN (0.52) POLBSMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL12431599 0.82 SMN1; SMN2 (0.70) POLBSMN1; SMN2HPGDKDM4EALDH1A1
SCHEMBL15288622 0.82 MKNK1 (0.67) —
SCHEMBL17389941 0.82 FASN (0.61) —
SCHEMBL17389761 0.81 FASN (0.55) POLBSMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL17389748 0.81 FASN (0.49) POLBSMN1; SMN2HPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3587406-B1 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER FORMA THERAPEUTICS INC (US) 2021-01-27 — — EP disclosed
Send feedback